Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Patricia D. Murphy"'
Autor:
Patricia D. Murphy, Rachel T. Klein, Kathleen S. Hruska, E Sutcliffe, Anna K. McGill, KJ Vogel Postula
Publikováno v:
Cancer Research. 79:P5-09
Background: PARP inhibitors (PARPi) are FDA approved for a subset of metastatic human epidermal growth factor receptor 2-negative (H2N) breast cancer patients who harbor a germline pathogenic or likely pathogenic variant (PV) in BRCA1/2, two of the m
Autor:
Kevin J. Arvai, Erin G. Sutcliffe, Lisa R. Susswein, Amy R. Stettner, Sheila R. Solomon, Patricia D. Murphy, Maegan E. Roberts, Kathleen S. Hruska, Rachel T. Klein, Megan L. Marshall, Stacey A. Miller
Publikováno v:
Cancer genetics.
Purpose Although CHEK2 is a well-established cancer gene, questions remain including whether risks vary substantially between different variants and whether biallelic carriers have higher risks than heterozygotes. We report on a cohort of individuals
Abstract PD7-11: The role of multi-gene hereditary cancer panels in male patients with breast cancer
Autor:
Anna K. McGill, KJ Vogel Postula, Rachel T. Klein, K Theobald, E Sutcliffe, Kathleen S. Hruska, Patricia D. Murphy, Kevin J. Arvai, LM Andolina
Publikováno v:
Cancer Research. 78:PD7-11
Background/Statement of Purpose: The role of cancer susceptibility genes in the male breast cancer population beyond BRCA1 and BRCA2 (BRCA) is not well defined. While breast cancer has been documented in men with pathogenic variants in a number of ot
Autor:
Rachel T. Klein, Lance Grau, Kristen J. Vogel Postula, Lisa R. Susswein, Patricia D. Murphy, Megan L. Marshall, Susan Hiraki
Publikováno v:
Journal of Urology. 201
Autor:
Zhixiong Xu, Natalie J. Carter, Kathleen S. Hruska, Susan Hiraki, Rachel T. Klein, Kevin J. Arvai, Lisa R. Susswein, Rebecca I. Torene, Kristin K. Zorn, Megan L. Marshall, Lauren Yackowski, Anna K. McGill, Patricia D. Murphy, Benjamin D. Solomon
Publikováno v:
Gynecologic oncology. 151(3)
The recognition of genes implicated in ovarian cancer risk beyond BRCA1, BRCA2, and the Lynch syndrome genes has increased the variety of testing options available to providers and patients. We report the frequency of pathogenic variants identified a
Autor:
Rachel Nusbaum, Megan L. Marshall, Lauren Yackowski, Lisa R. Susswein, Scott M. Weissman, Kristen J. Vogel Postula, Patricia D. Murphy, Gabi Richard, Jeffrey Bissonnette, Erica M. Vaccari, Wendy K. Chung, Daniel E. Pineda-Alvarez, Jessica K. Booker, Sherri J. Bale, M. Laura Cremona, Rachel T. Klein, Guido D. Pollevick, Zhixiong Xu, Kathleen S. Hruska, Federica Gibellini
Publikováno v:
Genetics in Medicine
Purpose: Germ-line testing for panels of cancer genes using next-generation sequencing is becoming more common in clinical care. We report our experience as a clinical laboratory testing both well-established, high-risk cancer genes (e.g., BRCA1/2, M
Autor:
Jessica K. Booker, Lauren Yackowski, Erica M. Vaccari, Maria L Cremona, Melanie Hussong, Kathleen S. Hruska, Patricia D. Murphy
Publikováno v:
Cancer Research. 75:P4-12
Background: Hereditary breast and ovarian cancer (HBOC) is a common indication for referral to cancer genetic counselors. Next generation sequencing panels allow for the efficient evaluation of many genes associated with increased risk of these cance
Autor:
Windy Berkofsky-Fessler, Constance Murphy, Deborah Pencarinha, Jessica K. Booker, Rebecca Yee Bassett, Haiyan Wan, Mingjuan Liao, Melanie Hussong, Nina Sanapareddy, Elisabeth McKeen, Kathleen S. Hruska, Patricia D. Murphy, Rachel Nusbaum, Erica S. Rinella, Rachel T. Klein, Zhixiong Xu, Joaquin Villar, Lisa R. Susswein, Maria L Cremona
Publikováno v:
Cancer Research. 75:P4-12
Introduction: Expansion of genetic testing technologies has brought multi-gene panels for cancer susceptibility into the clinic; however, the clinical utility of these next-generation sequencing (NGS) panels is largely unknown. Hypothesis: We hypothe
Publikováno v:
Science. 278:602-605
As increasing numbers of genes are identified and associated with human diseases, researchers are considering how to bring their discoveries from the research bench to the clinic. Holtzman, Murphy, Watson, and Barr, who were part of a Task Force on G
Autor:
David Burke, Eric L. Logigian, Joseph R. Madesen, Ernest W. Johnson, Peter J. Goadsby, S. E. Kaba, P. Pullicino, L. D. Jacobs, Michael A. Boss, Uma Ananth, Darcy Paquet, Patricia D. Murphy, Lynette Kiers
Publikováno v:
Muscle & Nerve. 18:126-130